STERIS share price today

STERIS plc's share price was $247.91 at the close on 4 November 2026. It has been stalling near its high for 3 weeks. That is 10.5% above its average price over the last 200 trading days. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 1 week in a row.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today STERIS plc is in stage 3. The phase helps read everything below.

In the last 52 weeks it traded between $203 and $269, and at that close it sat 69% of the way up from that low.

Over the last 10 years the share price moved +258% while the S&P 500 moved +261%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

STERIS plc paid $2.52 per share over the last four reported quarters. The most recent declaration was $0.63 for Jun 2026. At today's price of $247.91 that is a yield of 1.02%, based on dividends already paid, not a forecast.

A dividend is cash paid out for each share. The 12-month total is the four most recent quarters added together.

STERIS is on one of our US lists: S&P 500 companies.

STERIS plc earned $201 M of net profit in the Jun 2026 quarter, +12.9% on the same quarter a year earlier. That is the 5th quarter in a row of profit growth. Full-year FY26 profit was $785 M. Over 4 years profit has grown 34.1% a year on average. That is 13.5% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned $178 M. 1 of the last 12 reported quarters were loss-making.

For the full year, FY26 profit was $785 M (+27.5% on the year before).

Why profit moved: revenue changed +7.3% on a year earlier and the margin moved +1.4 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed +25.9% and revenue +8.4%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra dollar of revenue adds more to profit.

STERIS plc reported $1.5 B of revenue in the Jun 2026 quarter, +7.3% on the same quarter a year earlier. That is the 9th quarter in a row with growth on the year before. Over 4 years it has grown 8.9% a year on average. The last full year, FY26, came in at $5.9 B.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to $6.0 B.

The quarterly figures for FY22 do not add up to the full-year total on file, so those quarters are left out of the charts and sums.

FY26 revenue was $5.9 B, +8.7% on the year before.

Recent pace: the last four quarters grew +8.4% on average, against 8.9% a year over the longer run, so this year is growing at about the same pace as its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +8.4%, against +7.4% a year over the last 8 quarters (stabilising); profit over the last 12 months grew +24.6%, against +41.8% a year (rolling over).

STERIS plc's operating margin was 19.2% in the Jun 2026 quarter, 1.4 percentage points higher than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 5 years it has been between 16.1% and 18.7%. The latest quarter is above every full year in that period.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +1.4 percentage points on the year while gross margin changed +0.7 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales.

As noted under valuation: when margins are at a record, every ratio built on profit looks better than usual, so a low multiple can mislead.

Over the last 3 years, 194% of STERIS plc's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in $1.3 B of operating cash against $785 M of profit. After $369 M of spending on assets, $972 M was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

STERIS plc does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $1.1 B on assets over the last 3 years. Averaged over those years that is 6.2% of FY26 revenue a year.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Spending on assets: $1.1 B over the last 3 years.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

STERIS plc's P/E is 29.4×, near the low end of its own history: it has been lower only 18% of the time. Its usual P/E (the middle reading) is 43.8×, over 3.3 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

Keep one thing in mind: margins are the best this company has ever reported. A multiple that looks low against its own past can mislead when profit is at a record. If margins fall back, today's multiple is higher than it looks.